Peroxisome proliferator-activated receptor-γ agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells

Virology

Volumn 350, Issue 2, 2006, Pages 335-346

  Arnold, Ralf ^a   König, Wolfgang ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

15d PGJ2; A549; Bezafibrate; Ciglitazone; HEp 2; NHBE; PPAR ; PPAR ; RSV; Troglitazone

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 9 FLUORENYLMETHYLOXYCARBONYLLEUCINE; BEZAFIBRATE; CIGLITAZONE; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TROGLITAZONE; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ARTICLE; BRONCHUS MUCOSA; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; GENE EXPRESSION; HEP 2 CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; VIRUS GENE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

CHROMANS; HUMANS; LUNG; PPAR GAMMA; PROSTAGLANDIN D2; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUSES; THIAZOLIDINEDIONES; VIRUS REPLICATION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 33745244104     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.008     Document Type: Article

References (56)

1. American Academy of Pediatrics Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics 97 (1996) 137-140
2. Arnold R., and König W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively ICAM-1 expression. J. Immunol. 174 (2005) 7359-7367
3. Arnold, R., König, W., in press. Peroxisome-proliferator-activated receptor-γ agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells. Virology.
4. Arnold R., König B., Werchau H., and König W. RSV deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Virology 330 (2004) 384-397
5. Bailey S.T., and Ghosh S. 'PPAR'ting ways with inflammation. Nat. Immunol. 6 (2005) 966-967
6. 2 and the ligation of PPARγ. J. Clin. Invest. 112 (2003) 945-955
7. Birrell M.A., Patel H.J., McCluskie K., Wong S., Leonard T., Yacoub M.H., and Belvisi M.G. PPAR-γ agonists as therapy for diseases involving airway neutrophilia. Eur. Respir. J. 24 (2004) 18-23
8. Bitko V., Musiyenko A., Shulyayeva O., and Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11 (2005) 50-55
9. Bonazzi A., Mastyugin V., Mieyal P.A., Dunn M.W., and Laniado-Schwartzman M. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J. Biol. Chem. 275 (2000) 2837-2844
10. Bonville C.A., Mehta P.A., Krilov L.R., Rosenberg H.F., and Domachowske J.B. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone. Cell. Immunol. 213 (2001) 134-140
11. Bose S., Kar N., Maitra R., DiDonato J.A., and Banerjee A.K. Temporal activation of NF-κB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10890-10895
12. Bossert B., Marozin S., and Conzelmann K.K. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77 (2003) 8661-8668
13. Brooks M.J., Sadadeusz J.S., and Tannock G.A. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?. Curr. Opin. Pulm. Med. 10 (2004) 197-203
14. 2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J. Immunol. 171 (2003) 979-988
15. Cianci C., Yu K.L., Combrink K., Sin N., Pearce B., Wang A., Civiello R., Voss S., Luo G., Kadow K., Genovesi E.V., Venables B., Gulgeze H., Trehan A., James J., Lamb L., Medina I., Roach J., Yang Z., Zadjura L., Colonno R., Clark J., Meanwell N., and Krystal M. Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob. Agents Chemother. 48 (2004) 413-422
16. Clark R.B. The role of PPARs in inflammation and immunity. J. Leukocyte Biol. 71 (2002) 388-400
17. Daynes R.A., and Jones D.J. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. 2 (2002) 748-759
18. Dewhurst-Maridor G., Simonet V., Bornand J.E., Nicod L.P., and Pache J.C. Development of a quantitative TaqMan RT-PCR for respiratory syncytial virus. J. Virol. Methods 120 (2004) 41-49
19. Douglas J.L., Panis M.L., Ho E., Lin K.Y., Krawczyk S.H., Grant D.M., Cai R., Swaminathan S., Chen X., and Cihlar T. Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms. Antimicrob. Agents Chemother. 49 (2005) 2460-2466
20. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 10 (2004) 1-7
21. Everard M.L., Swarbrick A., Wrightham M., McIntyre J., Duncley C., James P.D., Sewell H.F., and Milner A.D. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child. 71 (1994) 428-432
22. Falsey A.R., Cunningham C.K., Barker W.H., Kouides R.W., Yuen J.B., Menegus M., Weiner L.B., Bonville C.A., and Betts R.F. Respiratory syncytial virus and influenza virus A infections in the hospitalised elderly. J. Infect. Dis. 172 (1995) 389-394
23. Fiedler M.A., Wernke-Dollries K., and Stark J.M. Inhibition of viral replication reverses respiratory syncytial virus-induced NF-κB activation and interleukin-8 gene expression in A549 cells. J. Virol. 70 (1996) 9079-9082
24. 2 on bleomycin-induced lung injury. Eur. Respir. J. 25 (2005) 225-234
25. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., and Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. J. Am. Med. Assoc. 283 (2000) 499-505
26. Hall C.B., and McCarthy C.A. Respiratory syncytial virus. In: Mandell G.L., Benett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases (2000), Churchill Livingstone, Philadelphia 1782-1801
27. Hayes M.M., Lane B.R., King S.R., Markovitz D.M., and Coffey M.J. Peroxisome proliferator-activated receptor γ agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J. Biol. Chem. 277 (2002) 16913-16919
28. Imamoto E., Yoshida N., Uchiyama K., Kuroda M., Kokura S., Ichikawa H., Naito Y., Tanigawa T., and Yoshikawa T. Inhibitory effects of pioglitazone on expression of adhesion molecules on neutrophils and endothelial cells. BioFactors 20 (2004) 37-47
29. IMPACT-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102 (1998) 531-537
30. Kimpen J.L.L. Management of respiratory syncytial virus infection. Curr. Opin. Infect. Dis. 14 (2001) 323-328
31. Kong X., Juan H.S., Kumar M., Behera A.K., Mohapatra A., Hellermann G.R., Mane S., Lockey R.F., and Mohapatra S.S. Respiratory syncytial virus infection activates STAT signalling in human epithelial cells. Biochem. Biophys. Res. Commun. 306 (2003) 616-622
32. Kong X., Juan H.S., Behera A., Peebles M.E., Wu J., Lockey R.F., and Mohapatra S.S. ERK-1/2 activity is required for efficient RSV infection. FEBS Lett. 559 (2004) 33-38
33. Kwak B.R., Myit S., Mulhaupt F., Veillard N., Rufer N., Roosnek E., and Mach F. PPARγ but not PPARα ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells. Circ. Res. 90 (2002) 356-362
34. Lee C.H., Olson P., and Evans R.M. Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144 (2003) 2201-2203
35. Lo M.S., Brazas R.M., and Holtzman M.J. Respiratory synytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79 (2005) 9315-9319
36. McDonald N.E., Hall C.B., Suffin S.C., Alexon C., Harris P.J., and Manning J.A. Respiratory syncytial virus infection in infants with congenital heart disease. N. Engl. J. Med. 307 (1982) 397-400
37. Michael L., Lazar M., and Mendelson C. Peroxisome proliferator-activated receptor gamma1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology 138 (1997) 3695-3703
38. Otake K., Omoto S., Yamamoto T., Okuyama H., Okada H., Okada N., Kawai M., Saksena N.K., and Fujii Y.R. HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated complexes. AIDS 23 (2004) 189-198
39. Pastey M.K., Crowe J.E., and Graham B.S. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and fascilitates virus-induced syncytium formation. J. Virol. 73 (1999) 7262-7270
40. Patel H.J., Belvisi M.G., Bishop-Bailey D., Yacoub M.H., and Mitchell J.A. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J. Immunol. 170 (2003) 2663-2669
41. 2 mediates peroxisome proliferator-activated receptor γ activation in human lung epithelial cells. J. Biol. Chem. 277 (2002) 33153-33163
42. 2. J. Biol. Chem. 278 (2003) 51251-51260
43. Reimers K., Buchholz K., and Werchau H. Respiratory syncytial virus M2-1 protein induces the activation of nuclear factor kappa B. Virology 331 (2005) 260-268
44. Rocchi S., Picard F., Vamecq J., Gelman L., Potier N., Zeyer D., Dubuquoy L., Bac P., Champy M.F., Plunket K.D., Leesnitzer L.M., Blanchard S.G., Desreumaux P., Moras D., Renaud J.P., and Auwerx J. A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell 8 (2001) 737-747
45. Shay D.K., Holman R.C., Roosevelt G.E., Clarke M.J., and Anderson L.J. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 183 (2001) 16-22
46. Spann K.M., Tran K.C., Chi B., Rabin R.L., and Collins P.L. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78 (2004) 4363-4369
47. Standiford T.J., Keshamouni V.G., and Reddy R.C. Peroxisome proliferator-activated receptor-γ as a regulator of lung inflammation and repair. Proc. Am. Thorac Soc. 2 (2005) 226-231
48. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4844-4849
49. 2 and thiazolinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J. Biol. Chem. 276 (2001) 48950-48955
50. Tang H., and McLachan A. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 1841-1846
51. Tian B., Zhang Y., Luxon B.A., Garofalo R.P., Casola A., Sinha M., and Brasier A.R. Identification of NF-κB-dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76 (2002) 6800-6814
52. Torrence P.F. RSV infections: developments in the search for new drugs. Drug News Perspect. 13 (2000) 226-233
53. Ueba O. Respiratory syncytial virus: I. Concentration and purification of the infectious virus. Acta Med. Okayama 32 (1978) 265-272
54. Wang A.C.C., Dai X., Luu B., and Conrad D.J. Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation. Am. J. Respir. Cell. Mol. Biol. 24 (2001) 688-693
55. Woerly G., Honda K., Loyens M., Papin J.P., Auwerx J., Staels B., Capron M., and Dombrowicz D. Peroxisome-proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J. Exp. Med. 198 (2003) 411-421
56. Zhao X., and Sullender W.M. In vivo selection of respiratory syncytial viruses resistant to palivizumab. J. Virol. 79 (2005) 3962-3968